Molecular properties associated with transporter-mediated drug disposition

Area of Science:

• Pharmacology
• Drug Discovery
• Computational Chemistry

Background:

• Membrane transporters are crucial for drug absorption, distribution, and elimination.
• Optimizing drug clearance and pharmacokinetics requires understanding drug-transporter interactions and structure-activity relationships (SAR).

Purpose of the Study:

• To introduce and apply the extended clearance classification system (ECCS) for early identification of drug clearance mechanisms.
• To utilize ligand-based modeling and quantitative structure-activity relationship (QSAR) to predict transporter affinity and guide drug design.

Main Methods:

• Application of the extended clearance classification system (ECCS) using readily available in vitro and physicochemical properties.
• Development of ligand-based modeling approaches to associate drug properties with transporter-mediated disposition.
• Building quantitative structure-activity relationship (QSAR) models for prospective prediction of transporter substrate/inhibitor affinity.

Main Results:

• The ECCS framework successfully identifies major clearance mechanisms and the role of membrane transporters in pharmacokinetics.
• Ligand-based modeling enables prediction of transporter affinity, aiding in early pharmacokinetic optimization.
• QSAR models facilitate the prediction of drug-drug interaction risks and tissue distribution.

Conclusions:

• The ECCS framework and QSAR modeling are valuable tools for early drug design and pharmacokinetic optimization.
• Predictive models improve the understanding of transporter roles in drug disposition and reduce drug-drug interaction risks.
• Further advancements require transporter protein crystal structures to refine predictive models.